BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15927188)

  • 1. Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer.
    Zadelaar AS; von der Thüsen JH; Boesten LS; Hoeben RC; Kockx MM; Versnel MA; van Berkel TJ; Havekes LM; Biessen EA; van Vlijmen BJ
    Atherosclerosis; 2005 Dec; 183(2):244-50. PubMed ID: 15927188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53.
    von der Thüsen JH; van Vlijmen BJ; Hoeben RC; Kockx MM; Havekes LM; van Berkel TJ; Biessen EA
    Circulation; 2002 Apr; 105(17):2064-70. PubMed ID: 11980686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of rheumatoid synovium in situ using a Fas ligand 'gene scalpel'.
    Zhang H; Gao G; Clayburne G; Schumacher HR
    Arthritis Res Ther; 2005; 7(6):R1235-43. PubMed ID: 16277676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability.
    Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Gómez-Hernández A; Arribas A; Ortega L; Tuñón J; Egido J
    Stroke; 2004 Feb; 35(2):458-63. PubMed ID: 14739407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
    Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
    Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
    Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals.
    Luo Z; Sata M; Nguyen T; Kaplan JM; Akita GY; Walsh K
    Circulation; 1999 Apr; 99(14):1776-9. PubMed ID: 10199871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus expressing Fas ligand gene decreases airway hyper-responsiveness and eosinophilia in a murine model of asthma.
    Chuang YH; Fu CL; Lo YC; Chiang BL
    Gene Ther; 2004 Oct; 11(20):1497-505. PubMed ID: 15269717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of wild-type and noncleavable Fas ligand by tetracycline-regulated adenoviral vectors to limit intimal hyperplasia in vascular lesions.
    Mano T; Luo Z; Suhara T; Smith RC; Esser S; Walsh K
    Hum Gene Ther; 2000 Aug; 11(12):1625-35. PubMed ID: 10954897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosis.
    von der Thüsen JH; Fekkes ML; Passier R; van Zonneveld AJ; Mainfroid V; van Berkel TJ; Biessen EA
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):357-62. PubMed ID: 14699016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
    Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
    Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
    Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.
    de Nooijer R; Verkleij CJ; von der Thüsen JH; Jukema JW; van der Wall EE; van Berkel TJ; Baker AH; Biessen EA
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):340-6. PubMed ID: 16306430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
    Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining.
    Yao Q; Glorioso JC; Evans CH; Robbins PD; Kovesdi I; Oligino TJ; Ghivizzani SC
    J Gene Med; 2000; 2(3):210-9. PubMed ID: 10894267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice.
    Dellas C; Schremmer C; Hasenfuss G; Konstantinides SV; Schäfer K
    Thromb Haemost; 2007 Jul; 98(1):220-7. PubMed ID: 17598016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced stabilization of atherosclerotic plaques in apolipoprotein E-knockout mice by combinatorial Toll-like receptor-1 and -2 gene silencing.
    Qi LH; Wang Y; Gao F; Zhang C; Ding SF; Ni M; Feng JB; Zhang Y
    Hum Gene Ther; 2009 Jul; 20(7):739-50. PubMed ID: 19278303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.